Mettler-Toledo International, Inc. MTD
- Market cap
- $30.4B
- P/E
- 33.9×
Follow MTD
Mettler-Toledo International, Inc. (MTD) Free cash flow
Mettler-Toledo International, Inc.'s free cash flow for fiscal 2025 was $848.6M, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $864.0M. Over the past ten years it has ranged from $337.2M (fiscal 2016) to $866.1M (fiscal 2024); the current reading is higher than 82% of that period. Mettler-Toledo International, Inc. ranks 10th of 52 Diagnostics & Research companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $848.6M | (2.01%) |
| FY2024 | $866.1M | 0.54% |
| FY2023 | $861.4M | 16.68% |
| FY2022 | $738.2M | (8.28%) |
| FY2021 | $804.9M | 26.69% |
| FY2020 | $635.3M | 25.18% |
| FY2019 | $507.5M | 17.90% |
| FY2018 | $430.5M | 7.38% |
| FY2017 | $400.9M | 18.87% |
| FY2016 | $337.2M | (5.87%) |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $282.6M | 130.94% |
| Mar 2026 | $122.4M | (33.52%) |
| Dec 2025 | $184.1M | (33.03%) |
| Sep 2025 | $274.9M | 29.36% |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| IQV IQVIA Holdings Inc. compare | $2.3B |
| DGX Quest Diagnostics Incorporated compare | $1.3B |
| A Agilent Technologies, Inc. compare | $1.3B |
| IDXX IDEXX Laboratories, Inc. compare | $1.2B |
| LH Labcorp Holdings Inc. compare | $1.2B |
| ILMN Illumina, Inc. compare | $931.0M |
| MTD Mettler-Toledo International, Inc. | $864.0M |
| WAT Waters Corporation compare | $366.6M |
| GH Guardant Health, Inc. compare | −$240.7M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on MTD
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement